整合素连接激酶抑制减弱SPARC对眼压及细胞外基质的影响
研究在小鼠、人眼前节灌注模型及人小梁细胞中探讨SPARC是否通过整合素连接激酶(ILK)调控眼压和细胞外基质。结果显示SPARC过表达升高眼压,而抑制ILK可减弱SPARC的升眼压效应并降低细胞外基质蛋白水平,提示ILK信号参与SPARC介导的小梁网细胞外基质稳态调节。
要点
- SPARC过表达使小鼠眼压升高1.87±0.50 mmHg,抑制ILK后眼压降低3.64±0.57 mmHg。
- 人眼前节中SPARC过表达使眼压升高2.10±0.25倍,加入shILK后眼压降低0.61±0.31倍。
- 人小梁细胞中抑制ILK可降低SPARC过表达引起的胶原I、胶原VI和层粘连蛋白水平升高。
核心结论
- 抑制ILK可减弱SPARC过表达对眼压和细胞外基质蛋白的影响,提示ILK信号可能参与SPARC介导的小梁网细胞外基质稳态调节通路。
研究设计与样本
- 研究使用携带人SPARC cDNA的腺病毒过表达SPARC,并使用携带靶向人ILK的shRNA的慢病毒抑制ILK,在活体小鼠、原代人小梁网细胞和灌注的人尸体眼前节中进行实验。
主要发现
- 小鼠中SPARC过表达使眼压升高1.87±0.50 mmHg(P=0.009,n=15),共感染抑制ILK使眼压降低3.64±0.57 mmHg(P<0.001,n=15),且组织学上细胞外基质蛋白较SPARC过表达组减少。
- 人眼前节中SPARC过表达使眼压升高2.10±0.25倍(P=0.021,n=4),加入shILK减弱SPARC效应并使眼压降低0.61±0.31倍(P=0.015,n=4)。
- 人小梁网细胞中Ad.SPARC感染升高SPARC和层粘连蛋白水平,共感染shILK降低ILK、胶原I、胶原VI和层粘连蛋白水平。
临床怎么用
- 该研究提示ILK信号通路可能是SPARC调控小梁网细胞外基质和眼压的潜在干预靶点,但尚未提供临床诊疗推荐。
局限性
- 原文未报告研究局限性;未来需评估下游转录因子以进一步阐明原发性开角型青光眼的发病通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The molecular pathway for increased outflow resistance in the trabecular meshwork (TM) remains unknown. Secreted protein, acidic and rich in cysteine (SPARC) has been shown to regulate intraocular pressure (IOP) correlating to extracellular matrix (ECM) alterations. In other tissues, SPARC binds integrin-linked kinase (ILK) and regulates ECM organization through signaling cascades. We hypothesized SPARC regulates ECM proteins partly through ILK in the TM. METHODS: Adenovirus carrying cDNA of human SPARC (Ad.SPARC) was used to overexpress SPARC and a lentivirus carrying short-hairpin RNA (shRNA) targeting human ILK (shILK) was used to inhibit ILK in live mice, primary human TM cells, and perfused human cadaveric anterior segments. IOP was measured in mice and human anterior segments. Selected ECM proteins were analyzed by immunoblotting and immunostaining. RESULTS: SPARC overexpression elevated IOP 1.87 ± 0.50 millimeters of mercury (mm Hg; P = 0.009, n = 15) in mice. Coinfection with ILK inhibition reduced IOP by 3.64 ± 0.57 mm Hg (P < 0.001, n = 15) and histologically reduced ECM proteins compared to SPARC overexpression. In human anterior segments, SPARC overexpression elevated IOP 2.10 ± 0.25-fold (P = 0.021, n = 4), whereas addition of shILK attenuated SPARC's effect and decreased IOP 0.61 ± 0.31-fold (P = 0.015, n = 4). In human TM cells, Ad.SPARC infection elevated levels of SPARC and laminin. Coinfection with shILK reduced levels of ILK, collagen I, collagen VI, and laminin. CONCLUSIONS: ILK inhibition attenuated the effects of SPARC overexpression on IOP and ECM proteins, suggesting ILK signaling may contribute to the pathway of SPARC-mediated regulation of ECM homeostasis in TM. Future studies evaluating the downstream transcription factors may provide an elucidated pathway for POAG pathogenesis.
引用
- Guo CW, Birrell S, Baillargeon S, et al. Integrin-Linked Kinase Suppression Reduces SPARC's Effect on Intraocular Pressure and Extracellular Matrix. Invest Ophthalmol Vis Sci. 2026. PMID: 42627120. doi:10.1167/iovs.67.10.53
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。